The ‘Primary’ Antiphospholipid Syndrome: Antiphospholipid Antibody Pattern and Clinical Features of a Series of 23 Patients

References

• Hughes G RV, Harris E N, Gharavi A E. The anticardiolipin syndrome. J. Rheumatol 1986; 13: 486–489
   PubMed Web of Science ®Google Scholar
• Sontheimer R D. The anticardiolipin syndrome. A new way to slice an old pie. or a new pie to slice. Arch Dermatol 1987; 123: 590–595
   PubMedGoogle Scholar
• Mueh J R, Herbst K D, Rapaport S I. Thrombosis in patients with the lupus anticoagulant. Ann Intern Med 1980; 92: 156–159
   PubMed Web of Science ®Google Scholar
• Boey M L, Colaço C B, Gharavi A E, Elkon K B, Loizou S, Hughes G RV. Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant. Br Med J 1983; 287: 1021–1023
   PubMed Web of Science ®Google Scholar
• Harris E N, Gharavi A E, Boey M L, et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983; 2: 1211–1214
   PubMed Web of Science ®Google Scholar
• Glueck H I, Kant K S, Weiss M A, Pollack V E, Miller M A, Coots M. Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants. Arch Intern Med 1985; 145: 1389–1395
   PubMedGoogle Scholar
• Colaço C B, Male D K. Anti-phospholipid antibodies in Syphillis and a thrombotic subset of SLE: distinct profiles of epitope specificity. Clin Exp Immunol 1985; 59: 449–456
   PubMedGoogle Scholar
• Cervera R, Font J, López-Soto A, et al. Isotype distribution of anticardiolipin antibodies in systemic lupus erythematosus. Prospective analysis of a series of 100 patients. Ann Rheum Dis 1990; 49: 109–113
   PubMedGoogle Scholar
• Harris E N, Chan J KH, Asherson R A, Aber V R, Gharavi A E, Hughes G RV. Thrombosis, recurrent fetal loss, and thrombocytopenia. Predicitive value of the anticardiolipin antibody test. Arch Intern Med 1986; 146: 2153–2156
   PubMedGoogle Scholar
• Petri M, Rheinschmidt M, Whiting-O'Keefe Q, Hellman D, Corash L. The frequency of lupus anticoagulant in systemic lupus erythematosus. A study of sixty consecutive patients by acitvated partial thromboplastin time. Russell viper venom time. and anticardiolipin antibody level. Ann Intern Med 1987; 106: 524–531
   PubMedGoogle Scholar
• Triplett D A, Brandt J T, Musgrave K A, Orr C A. The relationship between lupus anticoagulants and antibodies to phosppholipid. JAMA 1988; 259: 50–554
   Google Scholar
• Lockshin M D, Druzin M L, Goei S, et al. Antibodiy to car-diolipin as a predictor of fetal distress or death in regnant patients with systemic lupus erythematosus. N Engl J Med 1985; 313: 152–156
   PubMed Web of Science ®Google Scholar
• Khamashta M A, Cervera R, Asherson R A, et al. Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. Lancet 1990; 335: 1541–1544
   PubMed Web of Science ®Google Scholar
• Asherson R A, Harris E N. Anticardiolipin antibodies. Clinical associations. Postgrad Med J 1986; 62: 1081–1087
   PubMed Web of Science ®Google Scholar
• Manoussakis M N, Gharavi A E, Drosos A A, Kitridou R C, Moutsopoulos H M. Anticardiolipin antibodies in unselected autoimmune rheumatic disease patients. Clin Immunol Immunopathol 1987; 44: 297–307
   PubMedGoogle Scholar
• Asherson R A. A ‘primary’ antiphospholipid syndrome. J Rheumatol 1988; 15: 1742–1746
   PubMed Web of Science ®Google Scholar
• Mackworth-Young C G, Loizous S, Walport M J. Primary antiphospholipid syndrome: features of patients with raised anticardiolipin antibodies and no other disorder. Ann Rheum Dis 1989; 48: 362–367
   PubMedGoogle Scholar
• Asherson R A, Khamashta M A, Gil A, et al. Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus. lupus-like disease, and the primary antiphos pholipid syndrome. Am J Med 1989; 86: 391–399
   PubMed Web of Science ®Google Scholar
• Alarcon-Segovia D, Sanchez-Guerrero J. Primary antiphospholipid syndrome. J Rheumatol 1989; 16: 482–488
   PubMed Web of Science ®Google Scholar
• Asherson R A, Khamashta M A, Ordi-Ros J, et al. The “primary” antiphospholipid syndrome: Major clinical and serological features. Medicine (Baltimore) 1989; 68: 366–374
   PubMed Web of Science ®Google Scholar
• Gharavi A E, Harris E N, Asherson R A, Hughes G RV. Anti-cardiolipin antibodies: isotype distribuiton and phospholipid specificity. Ann Rheum Dis 1987; 46: 1–6
   PubMed Web of Science ®Google Scholar
• Staub H L, Khamashta M A, Harris E N, Chahade W H, Baguley E, Hughes G RV. Antiphospholipid syndrome andlupus anticoagulant in the absence of binding to negatively charged phospholipids (abstract). Arthritis Rheum 1989; 32(suppl)122
   Google Scholar
• Branch D W, Rote N S, Scott J R. The demonstration of lupus anticoagulant by enzyme-linked immunoadsorbent assay. Clin Immunol Immunopathol 1986; 39: 298–307
   PubMedGoogle Scholar
• Lopez-Soto A, Casals F J, Font J, Cervera R, Ingelmo M. Detection of antiphospholipid antibodies by ELISA-method with bovine thromboplastin as antigen. Throm Res 1989; 53: 623–628
   PubMedGoogle Scholar
• Tan E M, Cohen A S, Fries J, et al. The 1982 revised criteria for classification of SLE. Arthritis Rheum 1982; 25: 1271–1272
   PubMed Web of Science ®Google Scholar
• Harris E N, Gharavi A E, Patel S P, Hughes G RV. Evaluation of the anti-cardiolipin antibody test: resport of an international workshop held 4 April 1986. Clin Exp Immunol 1987; 68: 215–222
   PubMed Web of Science ®Google Scholar
• Thiagarajan P, Shapiro S S. Methods in Hematology: Disorders of thrombin formation other than hemophilia, R V Colman. Livinston, New York 1983; 101–103
   Google Scholar
• Green D, Hougie C, Kazmier F J, et al. Report of the working party on acquired inhibitors of coagulation: studies of the “lupus” anticoagulant. Thromb Haemostas 1983; 49: 144–146
   PubMed Web of Science ®Google Scholar
• Johnson A M. Immunoelectrophoresis. Manual of Clinical Laboratory Immunology. 3rd ed., N R Rose, H Friedman, J L Fahey. American Society for Microbiology, Washington 1986; 20–21
   Google Scholar
• Andrassy K, van der Woude F J. Detection of ANCA by imunofluorescence techniques. Neth J Med 1990; 36: 128–131
   PubMedGoogle Scholar
• Lachmann P J, Hobart M J. Complement technology. Handbook of experimental immunology. Vol 1. Blackwell Scient Publi., London 1978
   Google Scholar
• Alarcon-Segovia D, Delezé M, Oria C V, et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine (Baltimore) 1989; 68: 353–365
   PubMed Web of Science ®Google Scholar
• Mackworth-Young C. Antiphospholipid antibodies: more than just a disease marker. Immunol Today 1990; 11: 60–65
   PubMedGoogle Scholar
• Harris E N. Antiphospholipid antibodies. Br J Haematol 1990; 74: 1–9
   PubMed Web of Science ®Google Scholar
• Barbui T, Cortelazzo S, Galli M, et al. Antiphospholipid antibodies in early repeated abortions: a case-controlled study. Fetil Steril 1988; 50: 589–592
   PubMed Web of Science ®Google Scholar
• Balasch J, Font J, López-Soto A, et al. Antiphospholipid antibodies in unselected patients with repeated abortion. Hum Reprod 1990; 5: 43–46
   PubMed Web of Science ®Google Scholar
• Cervera R, Font J, Khamashta M A, Hughes G RV. Antiphospholipid antibodies: which and when. Postgrad Med J 1990; 66: 889–891
   PubMedGoogle Scholar
• Delezé M, Alarcon-Segovia D, Oria C V. Occurrence of both hemolytic anemia and thrombocytopenic purpura (Evans' syndrome) in systemic lupus erythematosus. Relationship to antiphospholipid antibodies. J Rheumatol 1988; 15: 611–615
   PubMedGoogle Scholar
• Hazeltine M, Rauch J, Danoff D, Esdaile J M, Tannenbaum H. Antiphospholipid antibodies in systemic lupus erythema tosus: Evidence of an association with positive Coombs' and hypocomplementemia. J Rheumatol 1988; 15: 80–85
   PubMed Web of Science ®Google Scholar
• Balestrieri G, Tincani A, Allegri F, Martinelli M, Sinico A, Cattaneo R. Antiphospholipid antibodies and red cell membrane. Clin Exp Rheumatol 1988; 6: 197
   Google Scholar
• Delezé M, Alarcón-Segovia D, Oria C V, et al. Hemocytopenia in systemic lupus erythematosus. Relationship to antiphospholipid antibodies. J Rheumatol 1989; 16: 926–930
   PubMedGoogle Scholar
• Asherson R A, Mayou S C, Merry P, Black M M, Hughes G RV. The spectrum of livedo reticularis and anticardiolipin antibodies. Br J Dermatol, 120: 215–221
   PubMedGoogle Scholar
• McHugh N J, Maymo J, Skinner R P, James I, Maddison P J. Anticardiolipin antibodies, livedo reticularis. and major cere- brovascular and renal disease in systemic lupus erythema tows. Ann Rheum Dis 1988; 47: 110–115
   PubMedGoogle Scholar
• Weinstein C, Miller H, Axtens R, Buchanan R, Littlejohn J O. Livedo reticularis associated with increased titers of Anticardiolipin antibodies in systemic lupus erythematosus. Arch Dermatol 1987; 123: 596–600
   PubMedGoogle Scholar
• Levine S R, Joseph R, D'Andrea G, Welch K MA. Migraine and the lupus anticoagulant. Report of cases and review of the literature. Cephalalgia 1987; 7: 93–99
   PubMed Web of Science ®Google Scholar
• Alarcón-Segovia D. Pathogenetic potential of antiphospholipid antibodies. J Rheumatol 1988; 15: 890–893
   PubMedGoogle Scholar
• Talal N. The etiology of systemic lupus erythematosus. Dubois Lupus erythematosus, D J Wallace, E L Dubois. Lea & Febiger, Philadelphia 1987; 39–43
   Google Scholar
• Khamashta M A, Harris E N, Gharavi A E, et al. Immune mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes. Ann Rheum Dis 1988; 47: 849–854
   PubMed Web of Science ®Google Scholar